Stifel Maintains Buy on Colgate-Palmolive, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Mark Astrachan maintains a Buy rating on Colgate-Palmolive (NYSE:CL) and raises the price target from $94 to $95.
April 29, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Mark Astrachan maintains a Buy rating on Colgate-Palmolive and raises the price target from $94 to $95.
The increase in the price target by Stifel reflects a positive outlook on Colgate-Palmolive's future performance. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100